41
Participants
Start Date
March 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
April 30, 2010
exenatide
5mcg twice a day, increasing to 10mcg twice a day for 24 weeks
placebo
5mcg twice a day, increased to 10mcg twice a day for 24 weeks
Medstar Research Institute, Washington D.C.
Mayo Clinic, Rochester
Oregon Health and Science University, Portland
Collaborators (1)
Amylin Pharmaceuticals, LLC.
INDUSTRY
Eli Lilly and Company
INDUSTRY
Oregon Health and Science University
OTHER